Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kishta Katipally is active.

Publication


Featured researches published by Kishta Katipally.


Journal of Organic Chemistry | 2009

Process Research and Development for a Tetrazole-Based Growth Hormone Secretagogue (GHS) Pharmaceutical Development Candidate

Akin H. Davulcu; Douglas D. McLeod; Jun Li; Kishta Katipally; Adam F. Littke; Wendel W. Doubleday; Zhongmin Xu; Cary W. McConlogue; Chiajen J. Lai; Margaret Gleeson; Mark D. Schwinden; Rodney L. Parsons

BMS-317180 (1) is a potent, orally active agonist of the human growth hormone secretagogue (GHS) receptor. This manuscript details the process research and development efforts that enabled the synthesis of the phosphate salt of 1 on a multi-kilogram scale. Key considerations in the development of this process focused on safe execution and the requirement for telescoped synthetic transformations (i.e., without isolation of intermediate products) to contend with a lack of suitably crystalline products.


Enzyme and Microbial Technology | 2001

Biochemical approaches to the synthesis of ethyl 5-(s)-hydroxyhexanoate and 5-(s)-hydroxyhexanenitrile

Venkata B. Nanduri; Ronald L. Hanson; Animesh Goswami; John Wasylyk; Thomas L. LaPorte; Kishta Katipally; Hyei-Jha Chung; Ramesh N. Patel

Three different biochemical approaches were used for the synthesis of ethyl 5-(S)-hydroxyhexanoate 1 and 5-(S)-hydroxyhexanenitrile 2. In the first approach, ethyl 5-oxo-hexanoate 3 and 5-oxo-hexanenitrile 4 were reduced by Pichia methanolica (SC 16116) to the corresponding (S)-alcohols, ethyl (S)-5-hydroxyhexanoate 1 and 5-(S)-hydroxyhexanenitrile 2, with an 80-90% yield and >95% enantiomeric excess (e.e). In the second approach, racemic 5-hydroxyhexanenitrile 5 was resolved by enzymatic succinylation, leading to the formation of (R)-5-hydroxyhexanenitrile hemisuccinate and leaving the desired alcohol 5-(S)-hydroxyhexanenitrile 2 with a yield of 34% (50% maximum yield) and >99% e.e. In the third approach, enzymatic hydrolysis of racemic 5-acetoxy hexanenitrile 6 resulted in the hydrolysis of the R-isomer to provide 5-(R)-hydroxyhexanenitrile, leaving 5-(S)-acetoxyhexanenitrile 7 with a 42% yield (50% maximum yield) and >99% e.e.


Tetrahedron Letters | 2002

Synthesis of substituted 2,3-dihydrobenzofuran in a process involving a facile acyl migration

Wen-Sen Li; Zhenrong Guo; John E. Thornton; Kishta Katipally; Richard Polniaszek; John K. Thottathil; Truc Chi Vu; Michael Wong

Abstract Reduction of 2,6-diacetoxy-2′-bromoacetophenone ( 10 ) with NaBH 4 led to 3,4-diacetoxydihydrobenzofuran ( 12 ) in a process involving acyl migration followed by cyclization. Subsequent hydrogenolysis gave 4-acetoxydihydrobenzofuran which, upon saponification, afforded 4-hydroxydihydrobenzofuran ( 8 ) in good yield. This approach is shown to be a general method for preparation of substituted dihydrobenzofurans.


Organic Letters | 2018

Adventures in Atropisomerism: Total Synthesis of a Complex Active Pharmaceutical Ingredient with Two Chirality Axes

Gregory L. Beutner; Ronald Carrasquillo; Peng Geng; Yi Hsiao; Eric C. Huang; Jacob Janey; Kishta Katipally; Sergei V. Kolotuchin; Thomas La Porte; Andrew Lee; Paul C. Lobben; Federico Lora-Gonzalez; Brendan Mack; Boguslaw Mudryk; Yuping Qiu; Xinhua Qian; Antonio Ramirez; Thomas M. Razler; Thorsten Rosner; Zhongping Shi; Eric M. Simmons; Jason Stevens; Jianji Wang; Carolyn S. Wei; Steven R. Wisniewski; Ye Zhu

A strategy to prepare compounds with multiple chirality axes, which has led to a concise total synthesis of compound 1A with complete stereocontrol, is reported.


Archive | 2006

Stereoselective reduction process for the preparation of pyrrolotriazine compounds

Ramesh N. Patel; Linda Nga Hoong Chu; Robert M. Johnson; Zhiwei Guo; Yijun Chen; Steven L. Goldberg; Ronald L. Hanson; Animesh Goswami; Kishta Katipally


Archive | 2000

FUSED PYRIDOPYRIDAZINE INHIBITORS OF cGMP PHOSPHODIESTERASE

Guixue Yu; John E. Macor; Soojin Kim; Hyei-Jha Chung; Michael Humora; Kishta Katipally; Yizhe Wang


Organic Process Research & Development | 2010

Development of a Scaleable Process for the Synthesis of a Next-Generation Statin

Lindsay A. Hobson; Otute Akiti; Subodh S. Deshmukh; Shannon Harper; Kishta Katipally; Chiajen J. Lai; Robert C. Livingston; Ehrlic Lo; Michael M. Miller; Srividya Ramakrishnan; Lifen Shen; Jan Spink; Srinivas Tummala; Chenkou Wei; Kana Yamamoto; John Young; Rodney L. Parsons


Tetrahedron Letters | 2012

Synthesis of ethyl 3-phenyl-4-(trifluoromethyl)isoxazole-5-carboxylate via regioselective dipolar cycloaddition

Michael A. Schmidt; Kishta Katipally; Antonio Ramirez; Omid Soltani; Xiaoping Hou; Huiping Zhang; Bang-Chi Chen; Xinhua Qian; Rajendra P. Deshpande


Organic Process Research & Development | 2017

Development of a Concise Multikilogram Synthesis of LPA-1 Antagonist BMS-986020 via a Tandem Borylation–Suzuki Procedure

Michael J. Smith; Michael Lawler; Nathaniel Kopp; Douglas D. McLeod; Akin H. Davulcu; Dong Lin; Kishta Katipally; Chris Sfouggatakis


Organic Letters | 2015

A Claisen Approach to 4′-Ed4T

William P. Gallagher; Prashant P. Deshpande; Jun Li; Kishta Katipally; Justin Sausker

Collaboration


Dive into the Kishta Katipally's collaboration.

Top Co-Authors

Avatar

Jun Li

Bristol-Myers Squibb

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge